NCT01716819View on ClinicalTrials.gov

Role of the Renin Angiotensin Aldosterone System in the Mechanisms of Transition to Heart Failure in Abdominal Obesity

NACompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Obesity, Abdominal
Interventions
OTHER

Urine sample

dosages on one spot and 24h collection

OTHER

Blood sample

dosages

OTHER

Assessment of sleep apnea syndrome

OTHER

Electrocardiogram

OTHER

Glucose tolerance test

OTHER

Echocardiography

OTHER

cardiac and abdominal magnetic resonance imaging

OTHER

Ambulatory blood pressure monitoring

OTHER

Echotracking

OTHER

Pulse wave velocity

OTHER

Composition of body mass by Dual x-ray absorptiometry

Trial Locations (1)

54500

CIC-P - INSERM - Institut Lorrain du Cœur et des vaisseaux, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT01716819 - Role of the Renin Angiotensin Aldosterone System in the Mechanisms of Transition to Heart Failure in Abdominal Obesity | Biotech Hunter | Biotech Hunter